Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Deferred Taxes: 2021-2025

Historic Deferred Taxes for Collegium Pharmaceutical (COLL) over the last 4 years, with Sep 2025 value amounting to -$12.1 million.

  • Collegium Pharmaceutical's Deferred Taxes fell 38.92% to -$12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.7 million, marking a year-over-year decrease of 51.45%. This contributed to the annual value of -$26.8 million for FY2024, which is 1145.42% down from last year.
  • Per Collegium Pharmaceutical's latest filing, its Deferred Taxes stood at -$12.1 million for Q3 2025, which was down 316.33% from -$2.9 million recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Deferred Taxes peaked at $2.1 million during Q3 2022, and registered a low of -$15.0 million during Q4 2021.
  • Moreover, its 3-year median value for Deferred Taxes was -$2.9 million (2025), whereas its average is -$4.1 million.
  • Its Deferred Taxes has fluctuated over the past 5 years, first surged by 656.23% in 2022, then plummeted by 9,491.30% in 2024.
  • Quarterly analysis of 5 years shows Collegium Pharmaceutical's Deferred Taxes stood at -$15.0 million in 2021, then surged by 92.82% to -$1.1 million in 2022, then skyrocketed by 68.65% to -$338,000 in 2023, then plummeted by 2,904.73% to -$10.2 million in 2024, then plummeted by 38.92% to -$12.1 million in 2025.
  • Its Deferred Taxes stands at -$12.1 million for Q3 2025, versus -$2.9 million for Q2 2025 and -$539,000 for Q1 2025.